Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis
Crossref DOI link: https://doi.org/10.1186/s12886-015-0101-4
Published Online: 2015-08-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Böhni, Sophie C.
Bittner, Mario
Howell, Jeremy P.
Bachmann, Lucas M.
Faes, Livia
Schmid, Martin K.
License valid from 2015-08-20